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The PRP18 gene, which had been identified in a screen for pre-mRNA splicing mutants in Saccharomyces
cerevisiae, has been cloned and sequenced. Yeast strains bearing only a disrupted copy of PRP18 are
temperature sensitive for growth; even at a low temperature, they grow extremely slowly and do not splice
pre-mRNA efficiently. This unusual temperature sensitivity can be reproduced in vitro; extracts immunode-
pleted of PRP18 are temperature sensitive for the second step of splicing. The PRP18 protein has been
overexpressed in active form in Escherichia coli and has been purified to near homogeneity. Antibodies directed
against PRP18 precipitate the U4/U5/U6 small nuclear ribonucleoprotein particle (snRNP) from yeast extracts.
From extracts depleted of the U6 small nuclear RNA (snRNA), the U4 and U5 snRNAs can be immunopre-
cipitated, while no snRNAs can be precipitated from extracts depleted of the U5 snRNA. PRP18 therefore
appears to be primarily associated with the U5 snRNP. The antibodies against PRP18 inhibit the second step
of pre-mRNA splicing in vitro. Together, these results imply that the U5 snRNP plays a role in the second step
of splicing and suggest a model for the action of PRP18.
The splicing of pre-mRNA takes place in two sequential
cleavage-and-ligation reactions (reviewed in references 26,
27, and 59). In the first step, the pre-mRNA is cut at the 5'
splice site, releasing the first exon; concomitantly, the 5'
phosphoryl group at the end of the intron is ligated to the 2'
hydroxyl of an internal adenosine, yielding a branched RNA
termed a lariat. In the second step, cleavage at the 3' splice
site is accompanied by ligation of the two exons, yielding the
product mRNA and releasing the intron as a lariat. Each
cleavage and ligation step is thought to be a concerted,
transesterification reaction in which the number of phos-
phodiester bonds is conserved. The identical reactions occur
during group II self-splicing, leading to the hypothesis that
RNA is also the catalyst in pre-mRNA splicing (36). The
splicing of pre-mRNA occurs on a large ribonucleoprotein
particle (RNP) called the spliceosome (13, 24), which con-
sists of five small nuclear RNAs (snRNAs), Ul, U2, U4, U5,
and U6, and a large but undetermined number of proteins
(17, 25, 39, 53).
pre-mRNA splicing occurs in all eukaryotes, and its mech-
anism appears to be conserved from yeasts to metazoans.
Although much has been learned about the functions of the
snRNAs and the splicing proteins, a complete accounting of
the role of any of the splicing factors cannot presently be
given. Each snRNA is part of a small nuclear RNP (snRNP)
(reviewed in reference 44). The Ul and U2 snRNPs are
involved in recognition of splice sites; Ul base pairs to the 5'
splice site, and U2 base pairs to the branchpoint sequence
(see reference 57 and previously cited reviews). The U4
snRNA base pairs to the U6 snRNA, and together they form
a single snRNP (12, 29). The U5 snRNP binds to the U4/U6
snRNP, forming a stable complex (9, 17, 39). It is in this
complex that U4, U5, and U6 enter the spliceosome (41, 61),
but they do not remain associated throughout the splicing
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reaction. U4 is apparently needed only for assembly of the
spliceosome, and it leaves the spliceosome before the first
cleavage reaction (76). U6 appears to be involved in both
steps of splicing (20), and a catalytic role for the U6 snRNA
in the splicing reaction has been proposed (14, 20, 67). The
role of the U5 snRNP has been difficult to uncover. It is a
large particle, apparently containing more proteins than the
other snRNPs (4). Recent genetic evidence suggests a role
for the U5 snRNP in the recognition of both the 5' and 3'
splice sites (48, 49).
A variety of proteins are required for splicing. They
include proteins involved in recognition and selection of the
5' and 3' splice sites and of the branchpoint sequence (see
cited reviews). Several proteins, known from genetic studies
in Saccharomyces cerevisiae, appear to be RNA-dependent
ATPases whose roles in splicing may be to alter the confor-
mations of the snRNAs or the pre-mRNA or to ensure the
fidelity of splicing (reviewed in reference 60). These AT-
Pases are needed during the assembly of the spliceosome,
during both steps of splicing, and for the release of the
mRNA. Many proteins associated with snRNPs are known
(reviewed in reference 44). For the most part, their functions
are unknown, although they are clearly involved in the
nuclear transport of snRNPs, in maintaining the structures of
individual snRNPs, and in the interactions between snRNPs.
Two of the best-studied snRNP proteins are the yeast PRP4
and PRP8 proteins. PRP4, a component of the U4 snRNP, is
involved in the binding of U4/U6 to U5 (7, 11, 52, 75); PRP8
is part of the U5 snRNP and appears to contact the pre-
mRNA during splicing (35, 43, 72).
In S. cerevisiae, screening of temperature-sensitive mu-
tants for splicing defects has been the principal method for
identifying splicing factors (46, 56, 71). Such screens have
yielded about 20 genes, known as PRP (for pre-mRNA
processing) genes, required for splicing. The PRP18 gene,
found by Vijayraghavan et al. (71), was of particular interest
because of its involvement in the second step of splicing.
Both in vivo and in vitro, the second step of splicing was
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found to be inhibited when PRP18 was defective (70, 71). At
the restrictive temperature, splicing in most of the tempera-
ture-sensitive prp mutants is blocked at the first step, often
as a result of failure of the spliceosome to assemble. In
contrast, the involvement of PRP18 in the second step of
splicing suggested that PRP18 might directly affect the
formation of covalent bonds in splicing and that study of it
could yield insights into the mechanisms of catalysis in
splicing. We report here the sequencing of the PRP18 gene,
the analysis of a null allele of PRP18, and the production of
active PRP18 protein. We find that PRP18 is a part of the U5
snRNP, implying a role for this snRNP in the second step of
splicing.
MATERIALS AND METHODS
Materials and strains. Plasmids were prepared from Esch-
erichia coli JM101. PRP18 was purified from E. coli
BL21(DE3) (65) transformed with pDH111. Yeast strains
SS330 and SS328 and the temperature-sensitiveprpl8 strain
503-6c are described in reference 71; strains EJ101 (a hisl
prbl-1122 prcl-126) and CBO18 (a CRYI pep4A::HIS3
prbl::hisGprclA::hisG) (from J. Robinson, California Insti-
tute of Technology) were used for making wild-type ex-
tracts. A haploid strain (a ura3-52 trpl-289 his3-532 lys2-801
ade2-101 snr7::TRPJ) transformed with plasmid pBWHisG7
was used for making the U5-depleted extract (50). Restric-
tion enzymes and DNA- and RNA-modifying enzymes were
from New England Biolabs, Boehringer Mannheim Bio-
chemicals, and Bethesda Research Laboratories. Sequenase
and sequencing reagents were from U.S. Biochemical.
[at-32P]dATP, [y-32P]ATP, and GeneScreen were from NEN;
[a-32P]UTP and the ECL Western immunoblotting detection
system were from Amersham. The Enzygraphic Web was
from International Biotechnologies, Inc. DE52 and CM52
were purchased from Whatman. Red Sepharose and protein
A-Sepharose were bought from Pharmacia. Nitrocellulose
and tresyl-activated agarose were from Schleicher &
Schuell. Leupeptin and aprotinin were from Boehringer
Mannheim Biochemicals. Phenylmethylsulfonyl fluoride,
benzamidine, pepstatin A, and S Sepharose were from
Sigma. Polyethyleneimine was from Miles Laboratories.
RNA molecular weight markers were from Bethesda Re-
search Laboratories. The PRP4 antibody (aPRP4) was ob-
tained from J. Banroques and is described in reference 7.
Antibodies to PRP18 were prepared by Cocalico Biologicals,
Inc., Reamstown, Pa.
Sequencing. The 2.5-kb BamHI-NruI fragment from
pUV18 (70) was cloned in the SmaI site of Bluescript KS+
and KS-, giving PRP18KS+ and PRP18KS-. Nested dele-
tions were made, and single-stranded DNAs were sequenced
with Sequenase according to the manufacturer's directions.
Both strands were sequenced. Sequence analysis was car-
ried out with GCG (18); homology searches were done with
FASTA, TFASTA (51), and BLAST (2).
Complementation. Four plasmids, pDH101 to 104, were
made by cloning the 2.5-kb BamHI-EcoRI, the 1.9-kb Hin-
dIII-EcoRI, the 1.2-kb BamHI-SphI, or the 1.1-kb BamHI-
EcoRV fragment (Fig. 1B) into the polylinker of the yeast
shuttle vector pPHYC18 (30), which contains the URA3
gene. The temperature-sensitiveprpl8 strain 503-6c (70) was
transformed (34) with pDH101 to 104, plated and restreaked
on selective medium (eight transformants for each plasmid),
and tested for growth at 37°C. Only 503-6c transformed with
pDH102 (HindIII-EcoRI) did not grow at 37°C.
Disruptions. Two plasmids, pDH120 and pDH121, were
made from PRP18KS+ by replacing the MscI-HindIII frag-
ment (within PRP18) or the SphI-MluI fragment (within
MUQ1) with the 1.8-kb BamHI-BamHI fragment containing
the HIS3 gene (64) (from C. O'Day, California Institute of
Technology). In pDH120 and pDH121, HIS3 is transcribed
in the same direction as PRP18. In two additional, analogous
plasmids, pDH120R and pDH121R, the orientation of the
HIS3 fragment was reversed. The four plasmids were cut
with EcoRI and XbaI and were transformed into SS330 x
SS328 (31), yielding the yeast strains DH120, DH120R,
DH121, and DH121R. Disruptions were verified by Southern
blotting. Tetrads were dissected, and markers and mating
types were checked. DH120 and DH120R were transformed
with pDH101, pDH104, and pUV18 (70), and tetrads were
again dissected and analyzed. Results were as follows. Only
half of the spores (from 15 tetrads, 23 of 60 spores survived)
from DH120 were viable, and all of the viable spores were
His-, suggesting that PRP18 is essential. However, the
inviable spores could be rescued only by pUV18, a 7-kb
clone which includes 3 kb upstream of PRP18 (from nine
tetrads, 26 of 36 spores survived, and all 12 viable His'
spores were Ura+). Viability of His' spores was not re-
stored by pDH101 (from 11 tetrads, 16 of 16 spores retaining
the plasmid were His-) or pDH104 (from 10 tetrads, 6 of 6
spores retaining the plasmid were His-). Hence, the lethality
of this disruption was most likely due to its effect on a gene
upstream ofPRP18. Transcript B in Fig. 2 is presumably the
transcript of this gene. All spores from DH120R were viable
(from 17 tetrads, 47 of 68 spores survived). The two His'
spores from each tetrad grew very slowly at 23 and 30°C
(doubling time of 6 h at 23°C) and did not grow at 37°C. The
temperature-sensitive defect could be remedied by any plas-
mid bearing the PRP18 gene. (Each of the three plasmids
was transformed into two independent His', temperature-
sensitive clones; four transformants of each clone were
analyzed.) Spore viability from the dissections of DH121 and
DH121R was low (9 of 28 viable spores from DH121 and 18
of 40 viable spores from DH121R); however, His' and His-
spores survived in roughly equal numbers, implying that
MUQI is not essential. His' spores from DH121R gave
small colonies, which were temperature sensitive, possibly
because of interference with expression of PRP18.
Transcription. Poly(A)+ RNA was made from S. cerevi-
siae EJ101 by standard methods (63) and was analyzed by
Northern (RNA) blotting of formaldehyde-agarose gels.
Twelve separate double-stranded probes (listed by the re-
striction sites at their ends and numbered as in Fig. 1A;
BamHI-SspI, -6 to -91; BamHI-ApaI, -6 to -214; BglII-
RsaI, 280 to 427; RsaI-HindIII, 428 to 656; HindIlI-ApaLl,
657 to 887;ApaLI-EcoRV, 888 to 1061; EcoRV-SphI, 1062 to
1235; BstXI-ScaI, 1336 to 1569; HincII-ClaI, 1774 to 1959;
ClaI-BstBI, 1960 to 2160; and NsiI-PstI, 2239 to 2529) were
purified by polyacrylamide gel electrophoresis (PAGE), la-
beled by random priming, and used to determine the extents
of the transcripts. Two single-stranded probes to the entire
region were used to determine the orientation of the tran-
scripts. Because the two 1,400-base transcripts could be
distinguished only by single-stranded probes, six additional
single-stranded probes (given 5' to 3', numbered as in Fig.
1A; 1 to 120, 111 to 1, 279 to 215, 311 to 215, 693 to 888, and
760 to 657) were used. The six short, single-stranded probes
were made by primer extension in the presence of
[a-32P]dATP on single-stranded DNA followed by cutting
with restriction enzyme and purification by denaturing
PAGE. Hybridizations were done in the presence of 50%
formamide (according to the manufacturer's instructions),
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CAAAC GTGATATTA_GAAAGTAGTGGCTCATTACTGTTCGTGACCAAGA
ATGTCTTATTCTTCTAATTCAACCTAA TTAAGAAGAGAATCGACCTTKaAAGCCCCAATGGAAAGAACTTCAATGTTT
M D L D L A S I L K G E I S K K K K E L A N S K G V Q P P C T
TTTCTCTAAAGTATAGAGCTAAATGGCCTAATCTGCCATATT ,-AAAGTGAAISCAAGhTGGCAACTCTiAAAGGTGTTCAGCCACCATGCAC
E K F Q P H E S A N I D E T P R Q V E Q E S T D E E N L S D N Q S D D I R T T I
TGAGAAATTCCAGCCACATGAATCCGCAAACATAGACGAAACACCGCGACAGGAACAGAAATACGGAAGAAAACCTGTCAGACAATCAGAGTGACGATATTAGGACCACCAT
S K L E N R P E R I Q E A I A Q D K T I S V I I D P S Q I G S T E G K P L L S M
TAGCAATAGAACGCGAGAAAGAGTGTCAAGACAAACCATCTCTGTAATCA7ATCGATCACAAATGTCTAC,AAGGAAAACCTCTTTTGTCAAT
K C N L Y I H E I L S R W K A S L E A Y H P E L F L D T K K A L F P L L L Q L R
GAAATG TTMATCTCGGTTTCTTAGACACTAAAAAAGCACTCTTTCCACTCCTACTGCAACTACG
R N Q L A P D L L I S L A T V L Y H L Q Q P K E I N L A V Q S Y M K L S I G N V
AAGGAACCAGTGCCCCCGGATTACTTATTTCCCTTGCGACCGTTCTCTATCATAACACTAAAGAAATAAATTAGCCGTTCAGTCCTATAGAACTCATATCGGCAATGT
A W P I G V T S V G I H A R S A H S K I Q G G R N A A N I M I D E R T R L W I T
GGCCTG7GCCTATTGGTGTTACTAGCTAGGCTCTCTCGTAGTGCACATTCGAAAATTCAAGGAGGCCGAA A ACATGCAATG TAC
S I K R L I T. F E E W Y T S N H D S L A * 14
CAGTATTAAAGATATATTTTGAAGAATGTTCAGACAGAACTGCTAATTGHTTGAACTATTI TATCCGTGCACGATATCATGCGGCCAAAAATAAG
, M T V N L D P D K V W
AAI DAAGAAG CF GA FATAGCCHGTTCAATTTTCCGAG GAACRAA EGGGAHCATGGATGACGGTAAACTTAGATCCGGATAAAGTTEGD
I D G C F D F T H H G H A G A I L Q A R R T V S K E N G K L F C G V H T D E D I
ATAGACGGCIY;CCTGATTTCACACATCATWGA7CGGAGCCATTTTCAGGCTCGTCGAACAGTTCAAAAGAAAATGGTAAACTATTCTGSTGGTGTGCATACCGATGAAGATATT
52 Q H N K G T P V M N S S E R Y E H T R S N R W C S E V V E A A P Y V T D P N W M
1321 CAGATAAGAA TGAAC TGTTCGGAAGTGGTTGAAGCGGCGCCATATTTACAGATCCCAATTGGATG
92 D K Y Q C Q Y V V H G D D I T I D A N G E D C Y K L V K E M G R F K V V K R T Y
1441 GATAAA CCAATATGTTGTTCATGG TATAAGTTGGTGAAAGAGATGGGGCGCTCAAGGTAGTTAAAAGAACATAT
G V S T T E I I H R I L T K K S L P P T H P D Y Y P T T Q E L S F Y S V A Q D A
GGCGKHCTVCCDV GG ACTGATTA TATCCCACCACCCAGGAATTGAG DHTATTCTGTCGCCCAAGATGCC
V S K H C Y V F Q R D L D N V L V N G G Y K F D A E D C V Y V D G D F D L F H M
GTTCAlAAACATTGTTATGTCTTTCAGAGGGATTTGGACAATGTCTTGTCAATGGTGGATACAAATTCGATG;AGAAGATTGTGTTTATGTACGGTTTATTATTCCATATG
212 G D I D Q L R K L K M D L H P D K K L I V G I T T S D Y S S T I M T M K E R V L
1801 TTCACCCCGATAAGAAACCATTATGACGATGAAGGAACGCGTCTTG
252 S V L S C K Y V D A V I I D A D A T S H S Q Y N C E K Y H I G T A V L T A A G K
1921 AGCGTTTTAAGTTGTAAATATGTTGATGCCGTTATTATCGATGCTAG C TTCATATT GGCACGGCTGTCCTCACTGCTGCCGGAAA
292 F S E Y L T K E L I V K R V E S Q R E V Y I A R N Q K K G M S I *
2041 TTCAGTGAATAC_ TT
_=TAICATGAGACAAAAGGGAATGTCCATATAAACAAATGTTGAAAACTTCTTC
2161 GAACGTAAA3TGGTGAGAAACTGTATTACTAAGTATAAGTAGCATGAAGTTTACAAGTAATGATATAACAGTGGAGAAGGCCACTATCCTTCAGAGATCAA
2281
2401
B PRP18
753bp
MUQi
969bp
I I
STF2
41
BI
XbBa Bg Ms H3
I
RV Sp MI RI
FIG. 1. (A) Sequence of the 2.5-kb complementing fragment (GenBank accession number L03536). Translation of the two long open
reading frames is shown. The open reading frame ofPRP18 extends from bp 269 through 1021, that ofMUQ1 extends from bp 1168 through
2136, and that of STF2 (not shown in panel A) extends from past the 3' end of the sequence through bp 2312. The mapped start sites of
transcription ofMUQ1 (transcript D in Fig. 2) are shown by the three arrows near base 1080. A possible polyadenylation site (for transcripts
A and D in Fig. 2) at base 2168 is underscored. (B) Schematic diagram of the sequence. The open reading frames for PRP18, MUQ1, and STF2
are shown by the arrows. Some relevant restriction sites are shown (Xb, XbaI; Ba, BamHI; Bg, BglII; Ms, MscI; H3, HindIII; RV, EcoRV;
Sp, Sphl; MI, Mlul; RI, EcoRI); the XbaI, BamHI, and EcoRI sites are in the polylinker of the vector.
and probed blots were washed for 2 h at 65°C in either 2x or
O.lx SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium
citrate) to ensure specificity in probing. The data acquired
were consistent only with the diagram shown in Fig. 2B. By
primer extension, the 5' end of the 1,200-base transcript was
mapped to bases 1075, 1076, and 1081.
Overproduction and purification of PRP18. pDH105 was
constructed by replacing the XbaI-BglII fragment in
PRP18KS+ with the annealed oligonucleotides 5'-CTA
GACCATGGACCTA-3' and 3'-TGGTACCTGGATCTAG
-5'. To make pDH111, pAR3039 (65) was cut with NdeI and
filled in with Klenow fragment. The 792-bp NcoI-EcoRV
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961
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120
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600
151
720
191
840
231
960
251
1080
11
1200
51
1320
91
1440
131
1560
171
1680
211
1800
251
1920
291
2040
323
2160
2280
2400
2521
AAAACCTTTTTTTATCTTGAAAACGCCCTCATTCCTTTTGGACG'r CAAACTTTTGTTCA7GCGATTGCAAATTTGAGCCTCTTCTATCTTTCTTGAACAC7GGGGGTATTTCACCAT
TATCAATTAAGTCATCAATCTCATCGCCTGGCTTACCCCAATTACCCTTGCCOGAACCTTGCTTCTTGATGTGATTTGGAGATTCACCGTAGTTACCAGTGTGCGAAAAGTAC7TTGGATC
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TABLE 1. Purification of PRP18 from E. colia
PRP18
Step Protein %(mg) % Amt Yield(mg)
Crude extract 85 10 -9
Ammonium sulfate precipitate 33 20 8 90
DE52-CM52 flowthrough 11 60 7 70
Red Sepharose 2 90 1.8 20
Sepharose S 0.25 99 0.25 3
a The purity of PRP18 was estimated from SDS-PAGE; we did not attempt
to determine the specific activity of PRP18.
fragment was excised from pDH105, filled in with Klenow
fragment, and ligated into the cut pAR3039. pDH111 was
placed in E. coli BL21(DE3) (65). After induction with
isopropylthiogalactopyranoside (IPTG), about 10% of the
cell protein was PRP18. The identity of the protein was
confirmed by N-terminal sequencing of gel-purified protein.
Solubility of overproduced PRP18 was determined by the
method of Nagai and Th0gersen (47). PRP18 was mostly
insoluble when cells were grown at 37°C but was completely
soluble when cells were grown at 30°C. PRP18 was moni-
tored during purification by sodium dodecyl sulfate (SDS)-
PAGE, which was also used to estimate the purity of the
protein. PRP18 migrated anomalously in SDS-polyacrylam-
ide gels with an apparent molecular weight of 34,000. Table
1 shows the results of one purification of PRP18. Cleared
lysates of E. coli BL21(DE3)/pDH111 were made with
lysozyme and Brij 58 as described elsewhere (66). Phenylm-
ethylsulfonyl fluoride, leupeptin, pepstatin A, benzamidine,
and aprotinin were included throughout the purification.
Nucleic acid was removed from the lysate by precipitation
with 0.5% polyethyleneimine. PRP18 remained in the super-
natant and was precipitated with 45% (NH4)2SO4. The pellet
was redissolved in buffer A (50 mM Tris [pH 7.5], 2 mM
1-mercaptoethanol, 1 mM EDTA, 10% [vol/vol] glycerol)-25
mM KCl and dialyzed against buffer A-25 mM KCl. The
dialysate was diluted to 3 mg of protein per ml with buffer
A-25 mM KCl and was loaded onto serial DE52 and CM52
columns. PRP18, about 60% pure, was recovered in the
flowthrough. The PRP18 pool was loaded on a Red
Sepharose column and eluted with a gradient of 35 to 1,000
mM KCl in buffer A. PRP18 eluted throughout the gradient,
peaking at 400 to 600 mM KCl. The peak fractions were
pooled, dialyzed against buffer B (25 mM morpholinoethane-
sulfonic acid [MES; pH 6.0], 2 mM P-mercaptoethanol, 1
mM EDTA, 10% [vol/vol] glycerol)-25 mM KCl and loaded
onto a Sepharose S column. The column was developed with
a 25 to 1,000 mM KCl-buffer B gradient. PRP18 eluted
between 180 and 210 mM KCl. The protein appeared homo-
geneous on a Coomassie blue-stained gel; silver staining of 1
,ug of PRP18 revealed several minor bands. The purified
protein was concentrated and dialyzed into buffer A-200mM
KCl-50% (vol/vol) glycerol and stored at -20°C. It is stable
for at least 1 year. Low yields, probably a result of aggre-
gation of PRP18, were a problem during the purification.
Analysis of various fractions by gel filtration showed some
aggregates early in the purification. The final product ap-
pears to be a dimer with an elution volume corresponding to
that of a 53-kDa (=2 x 28-kDa) protein.
Antibodies to PRP18. Antibodies against gel-purified
PRP18 were raised in rabbits. Two antibodies raised (acA and
aB) exhibited slightly different properties: aA reacted better
with PRP18 on Western blots and inhibited the second step
of splicing more completely than aB, but aoB immunoprecip-
itated snRNPs better than oA. Both antibodies met the
specificity criteria described in Results, and affinity-purified
antibodies were more similar. PRP18 was detected in West-
ern blots of extracts from wild-type yeast cells by using the
High Sensitivity Enzygraphic Web or the ECL system,
essentially according to the manufacturers' instructions. For
making affinity-purified antibodies, PRP18 was coupled to
tresyl-activated agarose, ammonium sulfate-fractionated
sera were loaded onto the column, and purified antibodies
were eluted sequentially at pH 2.5 and 11.5 (28).
Immunoprecipitation of snRNPs. Yeast extracts for immu-
noprecipitations were made from strain SS330, EJ101, or
CBO18a as described by Lin et al. (42). Immunoprecipita-
tions were carried out essentially as described previously (7)
except that preincubation of extracts under splicing condi-
tions was omitted unless specifically indicated; in addition,
KCl was substituted for NaCl throughout. Northern blotting
for the snRNAs was carried out as described previously (17)
except that the U6 probe was derived from plasmid pT7U6
(22). Blots were quantitated with a Molecular Dynamics
PhosphorImager. U5 snRNA was depleted by addition of a
large excess of two oligonucleotides complementary to bases
1 to 24 and to bases 124 to 139 of the U5 snRNA followed by
a 30-min incubation at 30°C under splicing conditions. About
75% of the U5 snRNA was cut at least once (40). Labeling of
immunoprecipitated RNAwith cytidine 3',5'-[5'-32P]bisphos-
phate (pCp) was performed as described previously (19).
Splicing reactions. Antibody inhibition of splicing was
carried out as described by Banroques and Abelson (7). For
the assay of splicing at different temperatures, PRP18-
depleted extract was prepared as described elsewhere (33).
Splicing reactions (42) were run at different temperatures by
bringing the extract and the splicing cocktail to the target
temperature and then mixing them. Quantitation was done
with a Molecular Dynamics Phosphorlmager.
Nucleotide sequence accession number. The sequence
shown in Fig. 1A has been assigned GenBank accession
number L03536.
RESULTS
Sequence, disruption, and transcription of the PRP18 gene.
A 2.5-kb fragment containing the PRP18 gene had been
cloned in S. cerevisiae by complementation of the prpl8
temperature-sensitive phenotype (70). Analysis of the segre-
gation of theprpl8 temperature-sensitive allele and a URA3
gene integrated at the locus of the cloned gene showed that
the cloned gene was indeed PRP18 (70). The sequence of the
2.5-kb fragment has been determined and is shown in Fig.
1A. As shown in the schematic diagram in Fig. 1B, the
sequenced region contains two open reading frames and part
of the previously known STF2 gene (77). By complementa-
tion, we found that the first of the two open reading frames
is PRP18; the region bounded by the BamHI site in the
vector and the EcoRV site (Fig. 1B) is sufficient to comple-
ment the prp18 temperature-sensitive defect, while the re-
gion bounded by the HindIII site and the EcoRI site in the
vector does not complement.
The PRP18 protein is encoded by bases 269 through 1021
of the sequence (Fig. 1A), giving a nearly neutral (calculated
pI of 6.6) protein of 251 amino acids (aa) (28,400 kDa). We
found no homology between PRP18 and other proteins in the
data base (2, 51), nor did we find any known motifs in PRP18
(5). The second open reading frame, named MUQ1, encodes
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a protein of 323 aa; MUQ1 has su
35% identity in the 138 aa betwc
phosphate cytidylyltransferase, wi
yeast (68) and rat (37) cells. (Nc
could be made between MUQ1 anc
proteins.) Disruption of the MUQI
essential.
To determine whether PRP18 is
a yeast strain in which the PRP18
we made a plasmid (pDH120R) in
PRP18 gene between the MscI aI
was replaced by a 1.8-kb BamHI-
ing the HIS3 gene (64). The choic
for replacement was dictated by ti
gene downstream of PRP18 and
gene upstream of PRP18 (Fig. 21
Methods). The plasmid was used
strain in which one copy of the PRi
HIS3 (58). All four spores general
were viable. However, the HisI
strain grew very slowly, taking sei
colonies at 23 or 30°C, and did n(23°C, these yeast cells accumulate
tent with the idea that their slow gro
deficiency. A plasmid bearing on]
complement the temperature-sens
the temperature sensitivity was ca
PRP18. Although we cannot rulec
yeast cells bearing the PRP18 disr
they make a partially functional fr
from the remaining portion of the I
expected for the disrupted gene
fragment from the C terminus of P1
can be made. Our experiments shc
PRP18 are temperature sensitive,
splice pre-mRNA efficiently even
in vitro experiment consistent with this conclusion is de-
scribed below.
We analyzed the transcription of the PRP18 and MUQI
genes and found that several transcripts are made from this
region. A Northern blot of the transcripts is shown in Fig.
MUQ 1 STF2 2A, and a schematic drawing is shown in Fig. 2B. The major
__________________
= transcript of PRP18 is 2,050 bp (A in Fig. 2) and includes
both the PRP18 and the downstream MUQI coding regions.
This apparently polycistronic transcript is presumably trans-
'iminm.4 F lated to make PRP18, but a second, more abundant tran-
D script (D), spanning only the MUQl gene, may be used to
make the MUQ1 protein. Transcript D starts only 55 bp from
the 3' end of the PRP18 coding region. A minor transcript
of poly(A)+ RNA, using the (C) apparently spans the PRP18 gene and ends within the
(B) schematic diagram of the MUQ1 gene. We do not know whether this unusually
ving the assignments of the complicated pattern of transcripts has any biological signif-liagram, the sequenced region icance.
VUQ, and STF2 open reading Overproduction and purification of PRP18 and raising of
s) are the various transcripts. antibodies to PRP18. To facilitate the study of PRP18, we
ated as heavier arrows. The prepared active PRP18 protein and made antibodies against
iscript B could not be readily PRP18. The PRP18 gene was placed under control of the T7
iated molar ratio of the tran- .
pIA, the start of transcript D is 440 promoter (65); In this construction, no alteration was
possible polyadenylation site made to the yeast PRP18 coding region. PRP18 was pro-
nce shows that there are two duced at high levels in E. coli bearing this plasmid. PRP18
ase 5' leader of transcript D was purified from E. coli by ammonium sulfate precipitation
30 to TGA-1151). Both short and by chromatography on DEAE-cellulose, carboxymethylf the MUQJ coding region at cellulose, Red Sepharose, and Sepharose S (Table 1 and
Materials and Methods). The protein was >98% pure by
SDS-PAGE and silver staining (data not shown). Gel filtra-
tion results suggested that PRP18 is a dimer in solution. The
ibstantial similarity (about purified PRP18 is active and restores splicing activity to
-en 7 and 144) to choline PRP18-depleted extracts (33).
hich has been cloned from We have raised antibodies in rabbits to gel-purified PRP18.
early identical alignments The antibodies can be used to detect PRP18 in Western blots
either of the homologous of extracts from wild-type yeast cells (Fig. 3). PRP18 was
gene showed that it is not identified by its mobility and its absence from extracts of
yeast lacking the PRP18 gene (Fig. 3, lane 6). From a
essential, we constructed comparison of the signal from PRP18 in lanes 1 and 3 of Fig.
gene was disrupted. First, 3, we estimate that PRP18 is only 2 x 10-'% of total yeast
which the portion of the protein, corresponding to approximately 2,000 copies per
nd HindlIl sites (Fig. 1B) cell. This copy number is comparable to the value of 200
BamHI fragment contain- obtained for yeast snRNAs (74). Several other proteins were
:e of this region of PRP18 detected with the oaPRP18, even following affinity purifica-he presence of the MUQI tion of the antibody. This background probably results from
by another, unidentified the extreme scarcity of the protein; other PRP proteins have
B; see also Materials and been similarly difficult to detect (7, 35, 52). The specificity of
to make a diploid yeast the antibodies was shown by two experiments; in Western
P18 gene was disrupted by blots of the proteins precipitated by aPRP18, only PRP18
ted from these yeast cells was detected (not shown), and the splicing activity of
' PRP18-disrupted yeast extracts immunodepleted of PRP18 was restored by addition
veral days to make visible of purified PRP18 protein, showing that only PRP18 was
ot grow at all at 37°C. At depleted (33). Affinity-purified antibodies were used in some
d unspliced RNA, consis- experiments to verify the specificity of the antibody.
owth was due to a splicing The antibodies inhibited splicing (Fig. 4). The second step
ly the PRP18 gene could of splicing was substantially, but not completely, inhibited;itive defect, showing that 2/3 lariat and exon 1 intermediates accumulated, and there
tused by the disruption of was a corresponding reduction in the amount of mRNA
)ut the possibility that the produced. With large amounts of antibody, there was some,
uption are viable because likely nonspecific, inhibition of the first step (Fig. 4). A vast
ragment of PRP18 protein excess of antibody was necessary to achieve good inhibition;
'RP18 gene, the sequence similar amounts were required in analogous experiments
shows that only a 68-aa with other splicing proteins (7, 16, 52). The inhibition could
RP18 (starting at Met-184) be reversed by the addition of excess purified PRP18 protein
)w that yeast cells lacking (data not shown). We have also carried out splicing in
grow slowly, and do not extracts which had been immunodepleted of PRP18 (de-
at a low temperature. An scribed in reference 33; see also Fig. 7). Analysis of the
VOL. 13, 1993
2964 HOROWITZ AND ABELSON
U)
0
U )
a)
N-~~ ~ ) ~')
(0
200K
g ontibabodyh!i oxtracil
so. E
CL, ~ ~CD- _
I--
ov / qrnvmwft "
-Is .-_
97K
-
_O lp
69K
45K--
PRP18- a"
31 K--
22K,dye - _-
1 2 3 4 5 6
FIG. 3. Western blot of yeast extracts with affinity-purified
otPRP18. Lanes: 1, 100 pg of purified PRP18; 2, approximately 2 ng
of total protein from E. coli overexpressing the PRP18 protein
[BL21(DE3)/pDH111 induced with IPTG]; 3, 10 jig of yeast protein
from a splicing extract from strain CBO18; 4, 10 ±g of yeast protein
from a splicing extract of a strain in which the U5 gene had been
turned off; 5, total protein from a zymolyase-SDS lysis of yeast
strain SS330; 6, total protein from a zymolyase-SDS lysis of yeast
strain DH120R-1, in which the PRP18 gene had been disrupted. For
this blot, affinity-purified antibody was used; PRP18 could also be
detected with aPRP18, but several additional proteins were also
detected. Some of the bands seen were also detected with the
preimmune serum or when the primary antibody was omitted.
PRP18 in yeast extracts appeared to have a slightly lower electro-
phoretic mobility than does PRP18 from E. coli; this difference may
result from the large difference in the amounts of protein loaded in
lanes 1 and 3. wt, wild type.
kinetics of splicing in these extracts shows that depletion of
PRP18 inhibits only the second step of splicing (33). Inhibi-
tion of the second step is incomplete in depleted extracts,
consistent with the idea that PRP18 is not absolutely re-
quired for splicing.
Immunoprecipitation of snRNPs. To determine whether
PRP18 is associated with any of the snRNPs involved in
splicing, we carried out a series of immunoprecipitation
experiments with aPRP18. Antibodies directed against the
PRP4 protein were used as positive controls in our experi-
ments; PRP4 is a yeast U4 snRNP protein (7, 11, 52, 75).
Yeast extracts were incubated with antibody bound to
protein A-Sepharose; bound RNA was extracted and run on
a denaturing gel, which was probed for the Ul, U2, U4, U5,
and U6 snRNAs. Results of such an experiment are shown in
Fig. 5. aPRP18 precipitated the U4, U5 (both S and L
forms), and U6 snRNAs from a yeast extract. About 8% of
the U4, 5% of the U5, and 4% of the U6 snRNAs were
precipitated; these recoveries were somewhat lower than
those seen in aPRP4 immunoprecipitations. The specificity
of this precipitation was shown by several results. First,
none of the snRNAs was precipitated by preimmune serum
(Fig. 5), and the same snRNAs were precipitated by affinity-
purified antibody (not shown). Second, the precipitation was
FIG. 4. Inhibition of splicing by affinity-purified aPRP18. Shown
is splicing of pre-mRNA following incubation with different amounts
of antibody as indicated. The positions of 2/3 lariat, intron, pre-
mRNA, mRNA, and exon 1 are indicated by symbols. Splicing
could be similarly inhibited with protein A-purified antibody, al-
though more antibody was required.
stable at moderate salt concentrations. At 50 mM KCI, there
was some nonspecific precipitation of Ul and U2 (Fig. 5) as
well as other RNA (determined by pCp labeling [7, 75]), but
between 100 and 300 mM KCl, the precipitation of U4, U5,
and U6 showed only a small salt sensitivity (Fig. 5). Immu-
noprecipitation of U4, U5, and U6 was also resistant to
heparin (not shown), which is effective in disrupting nonspe-
cific RNA-protein interactions (7, 17). Finally, we have
labeled the immunoprecipitated RNAs with pCp (data not
shown). U4, USS, and USL were detected; U6 cannot be
labeled with pCp (45). Several other RNAs were also de-
tected at about the same level as the U RNAs, but these
varied in precipitations from different extracts (also seen in
the studies reported in references 43 and 52). The pattern of
pCp labeling of RNAs precipitated by aPRP18 was identical
to that of RNAs precipitated by aPRP4, which had been
shown to precipitate U4, U5, and U6 snRNAs. All of the
data show that U4, U5, and U6 snRNAs are precipitated
specifically by caPRP18.
The U4, U5, and U6 snRNPs are thought to form a single
particle (17, 39); hence, the precipitation of all three snRNAs
by axPRP18 might result from interaction between PRP18
and only one snRNP. We used two types of experiments
to characterize the interactions between PRP18 and the
snRNPs further. First, we performed immunoprecipitations
at different salt concentrations or in the presence of ATP;
second, we immunoprecipitated snRNAs from extracts
which had been depleted of specific snRNAs. The precipi-
tation of U4, U5, and U6 was not significantly affected by
increasing the salt concentration from 100 to 300 mM;
however, above 300 mM there was a sharp decrease in the
precipitation of all of the snRNAs (Fig. 5). Precipitation of
all three snRNAs declined at the same rate as the KCl
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FIG. 5. Salt dependence of the immunoprecipitation of snRNAs.
Immunoprecipitations from yeast extracts were carried out with
preimmune antibody, aPRP18, or aPRP4 as described in the text.
The salt concentration was varied as indicated. The recovered
RNAs were detected by Northern blotting with DNA complemen-
tary to the Ul, U2, U4, U5, and U6 snRNAs.
concentration was increased from 300 to 400 mM (data not
shown). This decrease paralleled the decline in precipitation
of U5 snRNA by aPRP4 (Fig. 5) (7). We also tried to find
preferential precipitation of one of the snRNAs by preincu-
bating extracts under splicing conditions with ATP, which is
thought to affect the conformation of the U4/U5/U6 snRNP
(10, 17, 39), or by adding heparin to the extracts. Neither of
these changes individually affected the immunoprecipitation,
but inclusion of both ATP and heparin sharply reduced the
amounts of all the snRNAs precipitated (also observed with
aPRP4 (7]). We did not see preferential precipitation of any
of the snRNAs under any conditions.
We carried out immunoprecipitations with axPRP18 from
yeast extracts which had been depleted of either U5 or U6
snRNA. A U6-depleted extract was made in vitro by using a
deoxyoligonucleotide and RNase H (22). From this extract,
aPRP18 precipitated normal amounts of both U4 and U5
(Fig. 6A) but very little U6. Added T7-transcribed U6 RNA
can be assembled into snRNP (22) and was precipitated by
aPRP18 (Fig. 6A). This experiment shows that PRP18 bind-
ing to U4 and U5 does not require U6 and suggests that
PRP18 does not interact with the U6 snRNP. aPRP4 precip-
itates U4 and U5 following depletion of U6, suggesting that
U4 and U5 remain associated after destruction of U6 in yeast
extracts (6); similar results were found in HeLa extracts (10).
A U5-depleted extract was made from a yeast strain in
which expression of the U5 snRNA could be regulated (50).
Splicing extract was made from this strain several genera-
tions after the U5 gene had been turned off, leading to a
15-fold depletion of U5 (Fig. 6B) (40, 50, 61). aPRP18
precipitated only trace amounts of snRNAs from the U5-
depleted extract (Fig. 6B). Several results show that the
failure of xPRP18 to precipitate snRNPs from this extract is
a direct consequence of the absence of U5 and not a result of
any other problems with this extract. First, Krinke and
Abelson (40) have shown that some splicing activity can be
restored to US-depleted extracts by the addition of U5
snRNA, suggesting that the extract is otherwise competent
for splicing (see also reference 61). A small amount of added,
T7-transcribed US could be precipitated by aPRP18 or by
aPRP4 (Fig. 6B). Second, PRP18 is present at wild-type
levels in this extract and was seen in Western blots (Fig. 3,
lane 4). Third, aPRP4 precipitated both U4 and U6 snRNAs
from the US-depleted extract, although the ratio of U4 to U6
was higher than in wild-type extracts. Finally, a procedure
for partially depleting US snRNA by using two deoxyoligo-
nucleotides has been developed by Krinke and Abelson (40).
Precipitation of U4, US, and U6 from this extract by aPRP18
is reduced, consistent with the previous result. In summary,
our results show that PRP18 binding to the U4/US/U6
snRNP requires US but not U6 and hence that PRP18 is
likely part of the US snRNP.
We were not able to carry out a depletion of the U4
snRNA. Only one oligonucleotide has been reported to
facilitate RNase H cleavage of the yeast U4 snRNA (75), but
destruction of U4 with this oligonucleotide does not abolish
splicing activity (21). It seems unlikely a priori that PRP18
interacts primarily with U4, since U4 leaves the spliceosome
before PRP18 acts (76). The failure of ctPRP18 to precipitate
U4 in the absence of US confirms this idea.
Splicing at different temperatures in a PRP18-depleted
extract. Two findings, that PRP18 is essential only for
viability at high temperatures and that extracts immunode-
pleted of PRP18 retain some splicing activity (33), suggested
to us that a PRP18-depleted extract might have no splicing
activity at high temperatures. Correlations between in vivo
and in vitro requirements for PRP proteins have been seen
for several other proteins (46). We assayed splicing in a
PRP18-depleted extract (33) at different temperatures. Re-
sults of assays of splicing at 16, 23, 28, and 32°C using
preimmune* antibody-depleted and aPRP18-depleted ex-
tracts are shown in Fig. 7A. At each temperature, three time
points were analyzed; the times selected at each temperature
were different to account for differences in the reaction
rates. Under standard splicing conditions (23°C), depletion
of PRP18 greatly reduces the amount of mRNA produced
(33). The amount of mRNA made in the PRP18-depleted
extract declined substantially as the temperature was in-
creased from 16 to 32°C; mRNA was nearly undetectable in
the 32°C reactions. In the parallel reactions using preimmune
antibody-depleted extract, there was also a decrease in the
amount of mRNA produced, but this decrease was much
smaller than that seen in the aPRP18-depleted extracts.
In the absence of a well-defined kinetic model for splicing,
it is not possible to give a definitive interpretation of these
results. However, the following argument supports the idea
that the PRP18-depleted extract is temperature sensitive for
the second step of splicing. (The analysis of splicing kinetics
is discussed in more detail in reference 33.) Quantitative
analysis of the gel shown in Fig. 7A demonstrated that the
first step of splicing was unaffected by depletion of PRP18 at
all temperatures. Both the amounts of pre-mRNA and the
amounts of products, defined as RNA beyond the first step
of splicing, showed this result. The rate of the second step
(k2) can be estimated from the time course shown in Fig. 7A,
as described in the figure legend; the two rate constants,
k2(pre) and k2(aPRP18), are graphed as functions of the
temperature in Fig. 7B. While k2(pre) increased monotoni-
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FIG. 6. (A) Immunoprecipitation by aPRP18 from a U6-depleted extract, carried out at 150 mM KCl. About 95% of the U6 was degraded
in the presence of the oligonucleotide. Immunoprecipitations from a control (wild-type [wt]) extract, a U6-depleted extract, and a U6-depleted
extract to which T7-transcribed U6 had been added are shown; total RNA from a wild-type extract and a U6-depleted extract are also shown.
The RNAs were detected by Northern blotting. (B) Immunoprecipitation by preimmune antibodies, aPRP18, and aPRP4 from a U5-depleted
extract, carried out at 150 mM KCI. About 8% of the normal level of U5 (comparing GAL-U5 with normal levels of U5S plus USL) was
present. Shown are immunoprecipitations from a wild-type extract, an extract depleted of U5 snRNA in vivo, and an extract from the
U5-depleted extract to which T7-transcribed U5 had been added. In this assay, 1.5% of the T7-transcribed U5 could be precipitated by
aPRP18; about 6% of the U5 was precipitated from corresponding wild-type extracts.
cally with increasing temperature, k2(aLPRP18) fell with
increasing temperature. The ratio of k2(oPRP18) to k2(pre)
was 4 x 10-2 at 16°C and fell continuously to 3 x 10-3 at
32°C. Hence, there was a 15-fold reduction in the relative
rate of splicing as the temperature was increased from 16 to
32°C. From this reasoning, we believe that the PRP18-
depleted extract is temperature sensitive for the second step
of splicing.
We wondered whether a PRP18-depleted extract could be
irreversibly heat inactivated by heating at 32°C. The PRP18-
depleted extract was heated to 32°C for 20 min and then
immediately assayed for splicing activity at 23°C (Fig. 7A).
Both steps of the splicing reaction were slowed by approx-
imately twofold, but no specific inactivation of the second
step was seen, implying that the change in the extract which
leads to inhibition of the second step of splicing at 32°C was
reversible. Heat inactivation of extracts from a ppl8 tem-
perature-sensitive strain had been reported previously (70).
Since the defect in the prpl8 gene in this strain is not
presently known, our results cannot be directly compared
with this heat inactivation result.
DISCUSSION
The PRP18 gene was discovered in a screen of a bank of
temperature-sensitive yeast strains for splicing mutants (71),
and initial work on PRP18 showed that it was involved in the
second step of splicing (70, 71). In the present work, we have
demonstrated that PRP18 is a component of the U4/U5/U6
snRNP, binding principally to the U5 snRNP. We also have
showed that PRP18 is not absolutely required for splicing at
low temperatures but is required at higher temperatures. In
a separate report, we will demonstrate that PRP18 is in-
volved only in the second step of splicing. In extracts
depleted of PRP18, intermediates in the splicing pathway
accumulate; these intermediates can be chased to products
by the addition of PRP18 in the presence or absence of ATP
(33).
We have sequenced the PRP18 gene and found a 753-bp
coding region that does not show similarity to other genes in
the data bases. We constructed a disruption of the PRP18
gene and found that haploid yeast cells bearing only a
disrupted copy of the PRP18 gene were temperature sensi-
tive for growth. These yeast cells grew very slowly and
accumulated unspliced RNAs at 23°C, as did the previously
reported prpl8 temperature-sensitive strains (70). The tem-
perature sensitivity of splicing in the absence of PRP18 could
be reproduced in vitro. Yeast extracts immunodepleted of
PRP18 were able to splice pre-mRNA at low temperature
(23°C), albeit inefficiently; however, at high temperature
(32°C), little or no mRNA was produced. Only the second
step of the splicing reaction was affected by the depletion of
PRP18 at any temperature. Both the in vitro and in vivo
results suggest that PRP18 is not required for splicing at low
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FIG. 7. (A) Assay of splicing in preimmune antibody-depleted and aPRP18-depleted extracts. The positions 2/3 lariat intermediate, intron
lariat, pre-mRNA, mRNA, and the exon 1 intermediate are indicated symbolically at the left. The temperature and duration (in minutes) of
each splicing reaction are indicated above the lanes. For the three lanes marked 32°-->23°, PRP18-depleted extract was heated to 32°C for 20
min and then assayed for splicing at 23°C. (B) Rate constants. The rate constants k2(pre) (squares) and k2(aPRP18) (triangles) were estimated
as follows. We assumed that d[mRNA]/dt = k2[2/3 lariat] (assuming that the second step is essentially a unimolecular reaction and neglecting
degradation). Approximating d[mRNA]/dt by A[mRNA]/At leads to A[mRNA]/At k2[2/3 lariat]. The average value of [2/3 lariat] over the
interval At was calculated from PhosphorImager data for this gel, leading to a value for each k2. We used the first and second time points in
each case for calculating the rate constants. A very similar conclusion can be reached from comparisons of A[mRNA]/At at different
temperatures.
temperatures, although the second step of splicing is sub-
stantially slowed in its absence. At high temperatures,
PRP18 is necessary for the second step of splicing. This
finding can be interpreted in two ways. Either the role that
PRP18 plays in splicing is itself essential only at high
temperatures or its role is essential at all temperatures, but
another protein (or RNA) can inefficiently substitute for
PRP18 at low temperatures. Temperature sensitivity of null
mutants is rare, although it has been found for several
proteins involved in vacuolar protein sorting (30, 55). Be-
cause several genes in this pathway exhibit this phenotype,
it has been hypothesized that the process of vacuolar protein
sorting is required only at high temperatures.
A series of immunoprecipitation experiments showed that
PRP18 is an snRNP protein. aPRP18 precipitated the U4/
U5/U6 snRNP complex at low or moderate salt concentra-
tions. Extracts depleted of one of the snRNAs were used to
determine whether PRP18 is a component of only one of the
U4, U5, and U6 snRNPs. U4 and U5 could be precipitated
by aPRP18 from extract depleted of U6 snRNA, while no
snRNAs could be precipitated from extract depleted of U5
snRNA. We inferred that PRP18 is likely to be part of the U5
snRNP; since we were not able to immunoprecipitate U5
snRNP alone in our experiments, it is possible that PRP18 is
only part of the U4/U5/U6 snRNP, not part of the isolated
U5 snRNP.
The immunoprecipitation data suggest that PRP18 is not
tightly bound to the U5 snRNP. Above 350 mM KCl, no
snRNAs can be precipitated by aPRP18. In contrast, three
other yeast snRNP proteins (1, 7, 52, 62), as well as the
HeLa common snRNP proteins (32, 38), remain bound to the
snRNPs at much higher salt concentrations. The binding of
PRP18 to U4, U5, and U6 was unaffected by ATP. The effect
of ATP on the stability and formation of the U4/U5/U6
snRNP complex is not clear. In yeast cells, fractionation of
snRNPs on nondenaturing gels (17) or by glycerol gradients
(11) showed partial or complete (in the presence of heparin)
dissociation of U4/U6 from U5 upon addition of ATP.
Studies with antibody to PRP8, a yeast U5 protein, found
that U4/U6 was bound to U5 only in the presence of ATP
(43); this result is in accord with initial studies of HeLa
snRNPs using glycerol gradients (10). Work on PRP4 sug-
gested only a small effect of ATP on U4/U5/U6 stability;
however, in the presence of heparin, ATP apparently caused
U5 to dissociate from U4/U6, since U5 could no longer be
precipitated by aPRP4 (7). Work using purified U4/U5/U6
snRNP from HeLa cells found no effect of ATP on U4/
U5/U6 formation and stability (8). These disparate results
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suggest that a conformational change occurs to U4/U5/U6
upon addition of ATP; this change may render the snRNPs
more sensitive to heparin. Our work on PRP18 agrees with
the work on PRP4; we are able to immunoprecipitate U4,
U5, and U6 equally well in the presence or absence of ATP,
but in the presence of ATP and heparin, immunoprecipita-
tion is substantially reduced.
In yeast cells, one other U5 protein, PRP8, has been
identified biochemically (43). The characteristics of PRP8
are quite different from those of PRP18. Antibodies to PRP8
inhibit the first step of splicing (35), and otPRP8 precipitates
only U5 from extracts; however, in the presence of ATP,
aPRP18 precipitated U4 and U6 in addition to U5. Recently,
Frank et al. (23) have used genetic methods to identify
proteins (or RNAs) which interact with U5. They found four
genes, named SLUl, SLU2, SLU4, and SLU7, whose prod-
ucts are involved in splicing and interact genetically with U5.
Consistent with our results, they also found genetic interac-
tions between PRP18 and U5. Bach et al. (4) have identified
six proteins specific to the U5 snRNP in HeLa extracts. One
of these is immunologically related to the yeast PRP8 protein
(3, 54), but it is unknown whether a PRP18 analog may be
lurking among them.
An alternative interpretation of our immunoprecipitation
data is that PRP18 is only part of the U4/U5/U6 snRNP
particle, not part of any isolated snRNP. Such proteins are
known in HeLa cells (8). Some of our data support this
interpretation. First, we were not able to precipitate U5
individually under any of the conditions tested. Second,
conditions which are known to cause disassociation of U5
from the U4/U6 snRNP, including salt concentrations above
350 mM (7, 8) or incubations in the presence of ATP and
heparin, greatly reduced the amount of precipitation of all
snRNPs; the salt concentration above which aoPRP18 no
longer precipitates snRNPs is the same as that above which
aPRP4 no longer precipitates U5 snRNA. One result which
is apparently not consistent with this interpretation is that
atPRP18 still precipitated U4 and U5 when U6 had been
depleted, suggesting that intact U4/U5/U6 is not required for
snRNP binding by PRP18. Behrens and Luhrmann (8) have
recently found five proteins which are present only in the
U4/U5/U6 snRNP. These five proteins appear to be sufficient
to promote the assembly of the U4/U5/U6 snRNP from
purified U4/U6 and U5 snRNPs. One of these proteins is
apparently labile during heat shock, and its absence is
responsible for the absence of splicing in heat-shocked cells
(69). From the fractionation of these proteins, it appears that
they dissociate from the snRNPs at moderate salt concen-
trations (less than 500 mM). If PRP18 is indeed specific to the
U4/U5/U6 particle, then it is plausible that an analog of it
may be found among these five proteins.
Although U5 snRNP has long been presumed to be in-
volved in splicing, its role in splicing has been difficult to
establish. U5 snRNP was found to be associated with the
spliceosome (25), and native gel experiments suggested that
U5 joined the spliceosome with U4/U6 before the first
reaction in splicing (9, 17, 39, 53). The requirement for U5 in
splicing was shown first by genetic experiments in yeast cells
(50). Recent results support the notion that U5 is involved
early in splicing. First, in extracts depleted of U5 snRNP,
only early splicing complexes, lacking U4 and U6, form (41,
61). Second, suppression of mutations in the 5' splice site by
mutations in loop I of the U5 snRNA implies a role for U5 in
5' splice site recognition (48).
A role for U5 in the second step of splicing was suggested
by the 3' splice site binding experiments of Chabot et al. (15),
a finding which was disputed by Bindereif and Green (9).
Both in vivo and in vitro depletion of U5 appeared to lead to
preferential slowing of the second step of splicing (50, 73);
however, since the evidence now supports an essential role
for U5 in the first step of splicing, it would appear that these
depletions were incomplete, and the results are difficult to
interpret unambiguously. Evidence favoring the involve-
ment of U5 in the second step of splicing has come from the
recent genetic studies of Newman and Norman (49), who
found that mutations in the highly conserved loop I of U5
suppress mutations in the AG dinucleotide at the 3' splice
site. Their results imply that U5 snRNA is involved in the
recognition of the 3' splice site. The inferred interaction
between loop I of U5 and the 5' and 3' splice sites led to the
suggestion that U5 is involved in juxtaposing the splice sites,
in a manner analogous to that found in group II self-splicing
RNAs. Our results provide clear biochemical evidence that
the U5 snRNP is involved in the second step of splicing. The
antibody inhibition experiments show that PRP18 is involved
in the second step of splicing. In a separate report, we
present a kinetic analysis of splicing in an extract immuno-
depleted of PRP18. We show that PRP18 is involved exclu-
sively in the second reaction of splicing (33). Together with
the results presented here showing that PRP18 is part of the
U5 snRNP, our experiments imply a role for the U5 snRNP
in the second step of splicing. While the genetic data imply a
role for U5 in recognition of the 3' splice site, our results
suggest that PRP18 is involved in splicing at the time of the
ligation of the exons (33).
In summary, we find that PRP18 is a U5 snRNP protein
involved only in the second step of splicing. It seems likely
that PRP18 does not have a catalytic activity but is a
structural snRNP protein. From the unusual temperature
sensitivity of yeast cells lacking PRP18, we surmise that the
role of PRP18 is to stabilize a conformation that is otherwise
unstable at the nonpermissive temperature. The function of
PRP18, then, might be to stabilize a particular conformation
of the U5 snRNP or to orient the U5 snRNP within the
U4/U5/U6 snRNP or within the spliceosome.
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